Kelly MacDonald, Chief Accounting Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 2,797 shares at $11.25 ($31K) on 2020-11-06, disclosed to the SEC on 2020-11-10.
Scheduled sale ($31k) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.25 | 1,872 | $21K | 67.6% |
| 2 | $10.92 | 100 | $1K | 3.5% |
| 3 | $10.92 | 825 | $9K | 28.9% |
| Total | $11.14 avg | 2,797 | $31K | 100% |
| Filing → |
| IRWD | SELL | 2020-10-13 | $238K | — | Filing → |
| IRWD | SELL | 2020-08-19 | $6K | — | Filing → |
| IRWD | SELL | 2020-05-13 | $12K | — | Filing → |